Home > Healthcare > Biotechnology > Biotechnology R&D > Exosomes Market
Exosomes Market Share
- Report ID: GMI6862
- Published Date: Oct 2023
- Report Format: PDF
Exosomes Market Share
Market players operating in the exosomes is as mentioned below:
- Thermo Fisher Scientific, Inc.
- Bio-Techne Corp
- QIAGEN
- Beckam Coulter (Danaher Corp)
- Diagenode (Hologic Inc)
- Lonza
- Abcam
- RoosterBio, Inc.
- Miltenyi Biotech
- Fujifilm Holdings Corp
- Hitachi Chemical Diagnostics Inc
- Clara Biotech
Frequently Asked Questions (FAQ) :
Exosomes industry size was USD 250.8 million in 2022 and is anticipated to expand at 29.9% CAGR from 2023 to 2032 driven by the rising cases of cancer worldwide.
The kits & reagents products & services segment accounted for 44.9% of the exosomes industry in 2022 and is set to witness high demand through 2032 owing to extensive usage by researchers in R&D activities and production of exosome-based drugs and therapies.
North America held 55.5% of the global exosomes market in 2022 and is projected to record robust growth through 2032 driven by presence of well-developed and advanced healthcare infrastructure.
Some of the leading companies operating in the exosomes industry include Thermo Fisher Scientific, Inc., Bio-Techne Corp., QIAGEN, Beckam Coulter (Danaher Corp), Diagenode (Hologic Inc), Lonza, Abcam, Fujifilm Holdings Corp., Hitachi Chemical Diagnostics Inc., and Clara Biotech.
Exosomes Market Scope
×
Get a free sample of
Exosomes Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below